HUTCHMED (China) Limited (AIM:HCM)
202.00
-4.00 (-1.94%)
Mar 5, 2026, 4:40 PM GMT
HUTCHMED (China) Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 548.51 | 630.2 | 838 | 426.41 | 356.13 | Upgrade
|
| Revenue Growth (YoY) | -12.96% | -24.80% | 96.53% | 19.73% | 56.21% | Upgrade
|
| Cost of Revenue | 336.35 | 560.99 | 686.45 | 698 | 557.32 | Upgrade
|
| Gross Profit | 212.16 | 69.21 | 151.55 | -271.59 | -201.19 | Upgrade
|
| Selling, General & Admin | 103.03 | 112.91 | 133.18 | 136.11 | 127.13 | Upgrade
|
| Research & Development | 148.3 | - | - | - | - | Upgrade
|
| Operating Expenses | 251.32 | 112.91 | 133.18 | 136.11 | 127.13 | Upgrade
|
| Operating Income | -39.16 | -43.71 | 18.38 | -407.69 | -328.32 | Upgrade
|
| Interest Expense | -2.87 | -2.87 | -0.76 | -0.65 | -0.59 | Upgrade
|
| Interest & Investment Income | 49.88 | 40.08 | 36.15 | 9.6 | 2.08 | Upgrade
|
| Earnings From Equity Investments | 22.65 | 46.47 | 47.3 | 49.75 | 60.62 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 5.06 | 8.66 | -5.7 | 1.67 | Upgrade
|
| Other Non Operating Income (Expenses) | 13.94 | 5.13 | 1.65 | -5.97 | -11.89 | Upgrade
|
| EBT Excluding Unusual Items | 44.45 | 50.17 | 111.37 | -360.67 | -276.43 | Upgrade
|
| Gain (Loss) on Sale of Investments | 476.9 | - | - | - | 121.31 | Upgrade
|
| Asset Writedown | - | -4.8 | -5.77 | - | - | Upgrade
|
| Pretax Income | 521.34 | 45.36 | 105.6 | -360.67 | -155.12 | Upgrade
|
| Income Tax Expense | 63.61 | 7.19 | 4.51 | -0.28 | 11.92 | Upgrade
|
| Earnings From Continuing Operations | 457.73 | 38.17 | 101.09 | -360.39 | -167.04 | Upgrade
|
| Minority Interest in Earnings | -0.82 | -0.44 | -0.31 | -0.45 | -27.61 | Upgrade
|
| Net Income | 456.91 | 37.73 | 100.78 | -360.84 | -194.65 | Upgrade
|
| Net Income to Common | 456.91 | 37.73 | 100.78 | -360.84 | -194.65 | Upgrade
|
| Net Income Growth | 1111.03% | -62.56% | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 858 | 855 | 850 | 847 | 793 | Upgrade
|
| Shares Outstanding (Diluted) | 873 | 873 | 869 | 847 | 793 | Upgrade
|
| Shares Change (YoY) | 0.01% | 0.42% | 2.60% | 6.87% | 13.58% | Upgrade
|
| EPS (Basic) | 0.53 | 0.04 | 0.12 | -0.43 | -0.25 | Upgrade
|
| EPS (Diluted) | 0.52 | 0.04 | 0.12 | -0.43 | -0.25 | Upgrade
|
| EPS Growth | 1200.03% | -66.28% | - | - | - | Upgrade
|
| Free Cash Flow | -78.81 | -17.44 | 186.65 | -305.26 | -220.62 | Upgrade
|
| Free Cash Flow Per Share | -0.09 | -0.02 | 0.21 | -0.36 | -0.28 | Upgrade
|
| Gross Margin | 38.68% | 10.98% | 18.09% | -63.69% | -56.49% | Upgrade
|
| Operating Margin | -7.14% | -6.93% | 2.19% | -95.61% | -92.19% | Upgrade
|
| Profit Margin | 83.30% | 5.99% | 12.03% | -84.62% | -54.66% | Upgrade
|
| Free Cash Flow Margin | -14.37% | -2.77% | 22.27% | -71.59% | -61.95% | Upgrade
|
| EBITDA | -25.85 | -31.36 | 26.58 | -399.03 | -321.13 | Upgrade
|
| EBITDA Margin | -4.71% | -4.98% | 3.17% | -93.58% | -90.17% | Upgrade
|
| D&A For EBITDA | 13.31 | 12.34 | 8.21 | 8.66 | 7.19 | Upgrade
|
| EBIT | -39.16 | -43.71 | 18.38 | -407.69 | -328.32 | Upgrade
|
| EBIT Margin | -7.14% | -6.93% | 2.19% | -95.61% | -92.19% | Upgrade
|
| Effective Tax Rate | 12.20% | 15.86% | 4.27% | - | - | Upgrade
|
| Revenue as Reported | 548.51 | 630.2 | 838 | 426.41 | 356.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.